New Test for Diagnosing ANCA Vasculitis Now Available
source: pixabay.com

New Test for Diagnosing ANCA Vasculitis Now Available

According to a story from GlobeNewswire, Exagen, Inc. recently launched a testing panel called AVISE® Vasculitis AAV, which is designed to help physicians get fast and accurate data for patients…

Continue Reading New Test for Diagnosing ANCA Vasculitis Now Available
FDA Accepts Avacopan NDA for ANCA-Associated Vasculitis
source: pixabay.com

FDA Accepts Avacopan NDA for ANCA-Associated Vasculitis

In a recent press release, biopharmaceutical company ChemoCentryx announced FDA approval for a New Drug Application (NDA) for avacopan, a treatment for ANCA-associated vasculitis. According to the FDA, a New…

Continue Reading FDA Accepts Avacopan NDA for ANCA-Associated Vasculitis
Safety Reviews of Beovu, a Treatment for Neovascular AMD
bspence81 / Pixabay

Safety Reviews of Beovu, a Treatment for Neovascular AMD

  Despite rigorous testing before pharmaceutical products are introduced to the market, some still present negative side effects. In a discussion on Beovu (brolucizumab), used to treat neovascular macular degeneration…

Continue Reading Safety Reviews of Beovu, a Treatment for Neovascular AMD
New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment
source: pixabay.com

New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment

ChemoCentryx has just announced that they have submitted their New Drug Application to the FDA for a novel ANCA-associated vasculitis therapy. It is called avacopan and it's finally something non-steroidal.…

Continue Reading New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment
MRFF Funding Promotes Treatment Development for Patients with Rare Diseases
https://pixabay.com/en/money-piggy-bank-coins-finance-2180338/

MRFF Funding Promotes Treatment Development for Patients with Rare Diseases

  When it comes to researching and finding treatments for rare diseases, funding plays a crucial role. Recently, the Medical Research Future Fund (MRFF) Stem Cell Therapies Mission presented Monash…

Continue Reading MRFF Funding Promotes Treatment Development for Patients with Rare Diseases
ANCA Vasculitis Patients at an Increased Risk of Depression, Study Finds
source: pixabay.com

ANCA Vasculitis Patients at an Increased Risk of Depression, Study Finds

According to a story from ANCA Vasculitis News, a recent review study has determined that patients living with ANCA vasculitis and other related diseases are at a higher than average…

Continue Reading ANCA Vasculitis Patients at an Increased Risk of Depression, Study Finds
TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
mohamed_hassan / Pixabay

TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders

According to MedScape, tumor necrosis factor (TNF) inhibitors present severe issues for patients with autoimmune disorders. In particular, patients exposed to TNF inhibitors may experience inflammation throughout their central nervous…

Continue Reading TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
ANCA Vasculitis Could Be Severe Complication of Lemtrada
Rosser1954 / CC BY-SA (https://creativecommons.org/licenses/by-sa/4.0)

ANCA Vasculitis Could Be Severe Complication of Lemtrada

According to ANCA Vasculitis News, recent research shows that patients with multiple sclerosis who are being treated with Lemtrada are at greater risk of developing severe ANCA vasculitis. The drug therapy…

Continue Reading ANCA Vasculitis Could Be Severe Complication of Lemtrada
Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out
source: pixabay.com

Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out

  "A steak saved my life," writes columnist Damon Young, 41, in his article for GQ, as he shares the story of his diagnosis with Takayasu's arteritis. After over-indulging at dinner,…

Continue Reading Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out
Two Pyoderma Gangraenosum Patients Have Experienced Complete Healing in New Trial
source: pixabay.com

Two Pyoderma Gangraenosum Patients Have Experienced Complete Healing in New Trial

Pyoderma gangraenosum (PG) is a rare auto inflammatory disease which affects the skin. It unfortunately has no currently approved therapies. However, recent preliminary results from a Phase 2a trial have…

Continue Reading Two Pyoderma Gangraenosum Patients Have Experienced Complete Healing in New Trial
A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
source: pixabay.com

A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement

  A recent article in ANCA Vasculitis News highlighted a Chinese study of ANCA-associated vasculitis (AAV), a group of autoimmune diseases. An earlier Chinese study suggested that the risk of…

Continue Reading A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
Researchers are Now Able to Zoom in on the Mutations Causing Autoimmune Diseases
source: pixabay.com

Researchers are Now Able to Zoom in on the Mutations Causing Autoimmune Diseases

Without understanding the cause of disease it is difficult to understand how to most effectively care for patients. Instead of addressing the underlying cause of disease, physicians are forced to…

Continue Reading Researchers are Now Able to Zoom in on the Mutations Causing Autoimmune Diseases
New Guidelines for Vasculitis Treatment Recommend First-Line Biologics for Some Patients
source: pixabay.com

New Guidelines for Vasculitis Treatment Recommend First-Line Biologics for Some Patients

According to a story from Healio, new guidelines for the treatment of different forms of vasculitis recommend the use of biologic therapies as a first-line option for certain patients. It…

Continue Reading New Guidelines for Vasculitis Treatment Recommend First-Line Biologics for Some Patients
Low Doses of Glucocorticoids Could be Useful for Older Patients With ANCA Vasculitis
stevepb / Pixabay

Low Doses of Glucocorticoids Could be Useful for Older Patients With ANCA Vasculitis

According to a story from ANCA Vasculitis News, a recent study has found that a low-dose regimen of glucocorticoids that explicitly exclude the drug methyprednisolone can be a useful therapy…

Continue Reading Low Doses of Glucocorticoids Could be Useful for Older Patients With ANCA Vasculitis
The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis
qimono / Pixabay

The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis

According to a story from finanzen.ch, the US Food and Drug Administration (FDA) recently approved the drug rituximab (marketed as Rituxan) as a treatment in child patients aged at least…

Continue Reading The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis
Study Highlights Need for More Effective ANCA Vasculitis Classification
Belova59 / Pixabay

Study Highlights Need for More Effective ANCA Vasculitis Classification

According to a story from ANCA Vasculitis News, a recent study from Spain is highlighting the need for an updated classification system for ANCA-associated vasculitis that can predict patient prognosis…

Continue Reading Study Highlights Need for More Effective ANCA Vasculitis Classification
Major Infections Play a Key Role in the Prognosis of ANCA-Associated Vasculitis Patients
Source: Pixabay

Major Infections Play a Key Role in the Prognosis of ANCA-Associated Vasculitis Patients

According to a publication from ANCA Vasculitis News, a recent Spanish study of over 100 individuals diagnosed with ANCA-associated vasculitis found that major infections are a main cause of death…

Continue Reading Major Infections Play a Key Role in the Prognosis of ANCA-Associated Vasculitis Patients
Close Menu